Onco-Innovations Ltd. (ONNVF) Stock Statistics & Valuation Metrics
Total Valuation
Onco-Innovations Ltd. has a market cap or net worth of $72.82M. The enterprise value is $88.25M.
- Market Cap
- $72.82M
- Enterprise Value
- $88.25M
Share Statistics
Onco-Innovations Ltd. has 69,224,365 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 69,224,365
- Owned by Insiders
- 3.14%
- Owned by Institutions
- ―
Financial Efficiency
Onco-Innovations Ltd.’s return on equity (ROE) is -1.16 and return on invested capital (ROIC) is 0.00%.
- Return on Equity (ROE)
- -1.16
- Return on Assets (ROA)
- -0.76
- Return on Invested Capital (ROIC)
- 0.00%
- Return on Capital Employed (ROCE)
- 0.00
- Revenue Per Employee
- 0
- Profits Per Employee
- -420.65K
- Employee Count
- 1
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Onco-Innovations Ltd. is -20.06. Onco-Innovations Ltd.’s PEG ratio is 0.04.
- PE Ratio
- -20.06
- PS Ratio
- 0.00
- PB Ratio
- 29.07
- Price to FCF
- -23.78
- Price to Operating Cash Flow
- -21.75
- PEG Ratio
- 0.04
Income Statement
In the last 12 months, Onco-Innovations Ltd. had revenue of 0 and earned -420.65K in profits. Earnings per share was -0.01.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- 0
- Pretax Income
- -420.65K
- Net Income
- -420.65K
- EBITDA
- -265.63K
- Earnings Per Share (EPS)
- -0.01
Cash Flow
In the last 12 months, operating cash flow was -2.68M and capital expenditures 0, giving a free cash flow of -2.68M billion.
- Operating Cash Flow
- -2.68M
- Free Cash Flow
- -2.68M
- Free Cash Flow per Share
- -0.07
Dividends & Yields
Onco-Innovations Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -4.21%
- Earnings Yield
- -4.98%
Stock Price Statistics
- Beta
- 0.08
- 52-Week Price Change
- -83.06%
- 50-Day Moving Average
- 0.28
- 200-Day Moving Average
- 0.53
- Relative Strength Index (RSI)
- 29.98
- Average Volume (3m)
- 1,888
Important Dates
Onco-Innovations Ltd. upcoming earnings date is Dec 23, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Sep 14, 2026
- Next Earnings Date
- Dec 23, 2026
- Ex-Dividend Date
- ―
Financial Position
Onco-Innovations Ltd. as a current ratio of 2.62, with Debt / Equity ratio of 0.00%
- Current Ratio
- 2.62
- Quick Ratio
- 2.62
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 1.88
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Onco-Innovations Ltd. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Onco-Innovations Ltd. EV to EBITDA ratio is -22.50, with an EV/FCF ratio of -23.25.
- EV to Sales
- 0.00
- EV to EBITDA
- -22.50
- EV to Free Cash Flow
- -23.25
- EV to Operating Cash Flow
- -23.25
Balance Sheet
Onco-Innovations Ltd. has $1.41M in cash and marketable securities with $0.00 in debt, giving a net cash position of $1.41M billion.
- Cash & Marketable Securities
- $1.41M
- Total Debt
- $0.00
- Net Cash
- $1.41M
- Net Cash Per Share
- $0.02
- Tangible Book Value Per Share
- $0.05
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Scores
- Smart Score
- 2
- AI Score
- ―
